quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:09:22·1418d
NEWSRelease
Acer Therapeutics Inc. logo
Adicet Bio Inc. logo
Aeglea BioTherapeutics Inc. logo
+15

The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More

ACER· Acer Therapeutics Inc.ACET· Adicet Bio Inc.AGLE· Aeglea BioTherapeutics Inc.ALKS· Alkermes plcAZN· AstraZeneca PLCBMY· Bristol-Myers Squibb Company
Health Care
Original source

Companies

  • ACER
    Acer Therapeutics Inc.
    Health Care
  • ACET
    Adicet Bio Inc.
    Health Care
  • AGLE
    Aeglea BioTherapeutics Inc.
    Health Care
  • ALKS
    Alkermes plc
    Health Care
  • AZN
    AstraZeneca PLC
    Health Care
  • BMY
    Bristol-Myers Squibb Company
    Health Care
  • DCTH
    Delcath Systems Inc.
    Health Care
  • ENZ
    Enzo Biochem Inc.
    Health Care
  • GNCA
    Genocea Biosciences Inc.
    Health Care
  • GSK
    GSK plc
    Health Care
  • IBB
    iShares Nasdaq Biotechnology Index Fund
    n/a
  • LLY
    Eli Lilly and Company
    Health Care
  • NVAX
    Novavax Inc.
    Health Care
  • PFE
    Pfizer Inc.
    Health Care
  • REGN
    Regeneron Pharmaceuticals Inc.
    Health Care
  • SNY
    Sanofi
    Health Care
  • TPTX
    Turning Point Therapeutics Inc.
    Health Care
  • VERU
    Veru Inc.
    Health Care

Recent analyst ratings

  • Apr 20SNYUpdateBNP Paribas Exane$50.00
  • Mar 31REGNUpdatePiper Sandler$875.00
  • Mar 17LLYUpdateHSBC Securities$850.00
  • Mar 6REGNUpdateBarclays$923.00
  • Mar 2PFEUpdateArgus$35.00
  • Feb 25PFEUpdateRBC Capital Mkts$25.00

Related

  • PR13h
    Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.
  • PR16h
    Otarmeni™ (lunsotogene parvec-cwha) Approved by FDA as First and Only Gene Therapy for Genetic Hearing Loss; Regeneron to Provide Otarmeni for Free in the U.S.
  • PR20h
    Delcath Systems to Host First Quarter 2026 Earnings Call
  • PR21h
    Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
  • SEC21h
    SEC Form 6-K filed by Sanofi
  • PR22h
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • SEC22h
    SEC Form 6-K filed by AstraZeneca PLC
  • SEC23h
    SEC Form 6-K filed by GSK plc
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022